Medline Inc. Class A Common Stock (MDLN)

About MDLN

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and labora…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

45,000

Website

ir.medline.com/

Fundamentals

1-day range

$34.6$35.77

Market cap

$45.34B

P/E (trailing)

67.50

P/E (forward)

22.42

EPS (trailing)

$0.84

Dividend yield

—

Beta

0.78

Avg. volume

8.32M

Forecasts

26 analyst ratings

Medline Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• MDLN

  Medline Inc. Class A Common Stock

  $35.29

  ▲ 1.85%
  Market cap $45.34BP/E 67.50
  $32.49$50.88
• RMD

  ResMed Inc. Common Stock

  $240.24

  ▲ 1.90%
  Market cap $32.38BP/E 21.47
  $180.27$285.08
• DXCM

  DexCom Inc. Common Stock

  $90.8

  ▲ 1.69%
  Market cap $31.33BP/E 34.53
  $54.11$92.59
• BSX

  Boston Scientific Corporation Common Stock

  $46.83

  ▲ 0.34%
  Market cap $71.45BP/E 20.40
  $42.2$109.5
• BAX

  Baxter International Inc. Common Stock

  $26.12

  ▲ 0.77%
  Market cap $13.96BP/E —
  $15.73$30
• GMED

  Globus Medical Inc. Class A Common Stock

  $83.06

  ▲ 0.63%
  Market cap $11.01BP/E 21.55
  $54.15$101.4
• PODD

  Insulet Corporation Common Stock

  $145.15

  ▲ 1.21%
  Market cap $9.65BP/E 27.05
  $126.4$354.88

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• BTIG Reiterates Buy on Medline, Maintains $55 Price Target
  benzinga · 8/27/2026
• BTIG Reiterates Buy on Medline, Maintains $55 Price Target
  Benzinga · 8/27/2026
• Reported Earlier, FDA Says Medline Issued Correction For Convenience Kits Containing B. Braun Bupivacaine Hydrochloride Components, Identified As Most Serious Recall Type; B. Braun Reported 35 Serious Injuries, No Deaths
  Benzinga · 8/20/2026
• Artisan Global Opportunities Fund Q2 2026 Portfolio Review
  SeekingAlpha · 8/19/2026
• Allspring Large Cap Growth Fund Q2 2026 Performance Update
  SeekingAlpha · 8/14/2026
• Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products
  Benzinga · 8/13/2026
• JP Morgan Maintains Overweight on Medline, Lowers Price Target to $46
  Benzinga · 8/12/2026
• Wells Fargo Maintains Equal-Weight on Medline, Lowers Price Target to $34
  Benzinga · 8/11/2026
• TD Cowen Maintains Buy on Medline, Lowers Price Target to $45
  Benzinga · 8/10/2026

• GIC Private Ltd · August 7, 2026 · Sale

  590.3K @ $35.58
• Mozart Holdco, Inc. · August 6, 2026 · Conversion

  500.0K
• Mozart Holdco, Inc. · August 6, 2026 · J

  500.0K
• GIC Private Ltd · August 6, 2026 · Sale

  272.0K @ $35.33
• GIC Private Ltd · August 5, 2026 · Sale

  265.7K @ $36.48
• GIC Private Ltd · August 5, 2026 · Sale

  1.71M @ $35.46
• Liberman Alexander M. · June 15, 2026 · Tax Withholding

  872 @ $36.61
• Thomas W. Sweet · June 11, 2026 · Grant

  5.4K
• Todd M. Bluedorn · June 11, 2026 · Grant

  5.4K
• GALANTI RICHARD A · June 11, 2026 · Grant

  5.4K
• CORCORAN JESSI L · June 5, 2026 · Buy

  5.0K @ $34.15
• BX Mozart ML-2 Holdco L.P. · May 28, 2026 · J

  438.2K
• BX Mozart ML-2 Holdco L.P. · May 28, 2026 · Sale

  1.49M @ $36.54
• BX Mozart ML-2 Holdco L.P. · May 28, 2026 · Sale

  2.26M @ $36.54
• BX Mozart ML-2 Holdco L.P. · May 28, 2026 · Sale

  9.86M @ $36.54

Institutional Ownership

March 31, 2026

Total shares held

621.79M

Total value held

$27.17B

Institutional holders

306